Ovid Therapeutics Inc.·4

Feb 27, 5:24 PM ET

Rona Jeffrey A 4

4 · Ovid Therapeutics Inc. · Filed Feb 27, 2023

Insider Transaction Report

Form 4
Period: 2023-02-23
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-23+175,000175,000 total
    Exercise: $2.50Exp: 2033-02-22Common Stock (175,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2024 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION